These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30807747)

  • 1. Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2.
    Ye J; Guan M; Lu Y; Zhang D; Li C; Li Y; Zhou C
    Eur J Pharmacol; 2019 Jun; 852():151-158. PubMed ID: 30807747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury.
    Zhang Y; Xu T; Wu B; Chen H; Pan Z; Huang Y; Mei L; Dai Y; Liu X; Shan X; Liang G
    J Cell Mol Med; 2017 Apr; 21(4):746-757. PubMed ID: 27860279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2.
    Zhang YL; Zhang WX; Yan JQ; Tang YL; Jia WJ; Xu ZW; Xu MJ; Chattipakorn N; Wang Y; Feng JP; Liu ZG; Liang G
    Acta Pharmacol Sin; 2022 Jan; 43(1):76-85. PubMed ID: 34480112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury.
    Zhang Y; Wu J; Ying S; Chen G; Wu B; Xu T; Liu Z; Liu X; Huang L; Shan X; Dai Y; Liang G
    Sci Rep; 2016 Apr; 6():25130. PubMed ID: 27118147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shikonin inhibits myeloid differentiation protein 2 to prevent LPS-induced acute lung injury.
    Zhang Y; Xu T; Pan Z; Ge X; Sun C; Lu C; Chen H; Xiao Z; Zhang B; Dai Y; Liang G
    Br J Pharmacol; 2018 Mar; 175(5):840-854. PubMed ID: 29243243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L6H9 attenuates LPS-induced acute lung injury in rats through targeting MD2.
    Wu P; Yan H; Qi J; Jia W; Zhang W; Yao D; Ding C; Zhang Y; Chen M; Cai X
    Drug Dev Res; 2020 Feb; 81(1):85-92. PubMed ID: 31693211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hesperetin ameliorates lipopolysaccharide-induced acute lung injury in mice through regulating the TLR4-MyD88-NF-κB signaling pathway.
    Wang N; Geng C; Sun H; Wang X; Li F; Liu X
    Arch Pharm Res; 2019 Dec; 42(12):1063-1070. PubMed ID: 31802426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of myeloid differentiation factor 2 by baicalein protects against acute lung injury.
    Chen H; Zhang Y; Zhang W; Liu H; Sun C; Zhang B; Bai B; Wu D; Xiao Z; Lum H; Zhou J; Chen R; Liang G
    Phytomedicine; 2019 Oct; 63():152997. PubMed ID: 31254764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radix Glycyrrhizae extract and licochalcone a exert an anti-inflammatory action by direct suppression of toll like receptor 4.
    Cai M; Xu YC; Deng B; Chen JB; Chen TF; Zeng KF; Chen S; Deng SH; Tan ZB; Ding WJ; Zhang SW; Liu B; Zhang JZ
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115869. PubMed ID: 36309116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release.
    Liu XX; Yu DD; Chen MJ; Sun T; Li G; Huang WJ; Nie H; Wang C; Zhang YX; Gong Q; Ren BX
    Int Immunopharmacol; 2015 Apr; 25(2):370-6. PubMed ID: 25724384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of caffeic acid phenethyl ester derivatives as novel myeloid differentiation protein 2 inhibitors for treatment of acute lung injury.
    Chen L; Jin Y; Chen H; Sun C; Fu W; Zheng L; Lu M; Chen P; Chen G; Zhang Y; Liu Z; Wang Y; Song Z; Liang G
    Eur J Med Chem; 2018 Jan; 143():361-375. PubMed ID: 29202400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperlongumine mitigates LPS-induced inflammation and lung injury via targeting MD2/TLR4.
    Tang Y; Zhang W; Wu L; Bai B; Zheng B; Li M; Tang Y; Zhu X; Zhang Y; Wang Y; Zhang B
    Biochem Biophys Res Commun; 2023 Jan; 642():118-127. PubMed ID: 36566563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization and anti-inflammatory evaluation of methyl gallate derivatives as a myeloid differentiation protein 2 inhibitor.
    Qiu Y; Xiao Z; Wang Y; Zhang D; Zhang W; Wang G; Chen W; Liang G; Li X; Zhang Y; Liu Z
    Bioorg Med Chem; 2019 Oct; 27(20):115049. PubMed ID: 31466835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice.
    Tang Y; Chen Y; Chu Z; Yan B; Xu L
    Eur J Pharmacol; 2014 Jan; 723():494-500. PubMed ID: 24161915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoids from Radix Tetrastigmae improve LPS-induced acute lung injury via the TLR4/MD-2-mediated pathway.
    Liu DD; Cao G; Han LK; Ye YL; Zhang Q; Sima YH; Ge WH
    Mol Med Rep; 2016 Aug; 14(2):1733-41. PubMed ID: 27314522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation.
    Tao L; Cao F; Xu G; Xie H; Zhang M; Zhang C
    Phytother Res; 2017 Jul; 31(7):1097-1106. PubMed ID: 28512854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2.
    Luo W; Yang LB; Qian CC; Ma B; Manjengwa GM; Miao XM; Wang J; Hu CH; Jin B; Zhang LX; Zheng C; Liang G; Wang Y
    Acta Pharmacol Sin; 2022 Jul; 43(7):1758-1768. PubMed ID: 34737421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.